• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.27% Nasdaq Down 0.19%

    Celgene Corporation (CELG)

    -NasdaqGS
    131.08 Down 0.39(0.30%) Aug 4, 3:59PM EDT
    |After Hours : 130.26 Down 0.82 (0.63%) Aug 4, 6:49PM EDT
    Add to Portfolio
    Prev Close:131.47
    Open:131.64
    Bid:130.26 x 100
    Ask:131.50 x 200
    1y Target Est:152.89
    Beta:2.04
    Earnings Date:Oct 21 - Oct 26 (Est.)
    Day's Range:130.03 - 132.00
    52wk Range:83.16 - 140.72
    Volume:2,587,133
    Avg Vol (3m):4,567,220
    Market Cap:103.97B
    P/E (ttm):49.63
    EPS (ttm):2.64
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    CELGDown 0.30%103.97B
    JNJDown 0.22%276.75B

    Key Statistics

    Forward P/E (1 yr):21.92
    P/S (ttm):12.37
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :4.81
    Quarterly EPS Est (Sep-15) :1.21
    Mean Recommendation*:1.9
    PEG Ratio (5 yr expected):1.08

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Celgene Corporation, a biopharmaceutical company, discovers, develops, and commercializes therapies to treat cancer and inflammatory diseases in the United States and Internationally. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback